EcoDrugPlus

Histamine H2 Receptor-Like

Ensembl ID : ENSPNAG00000005161
Gene Symbol: LOC108438844
2 Cross references
189 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSPNAG00000001104
Gene Symbol: HRH1
4 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSPNAG00000026629
Gene Symbol: HRH2
4 Cross references
182 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSPNAG00000029761
Gene Symbol: HDAC1
3 Cross references
309 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSPNAG00000004519
Gene Symbol: HDAC10
3 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSPNAG00000000189
Gene Symbol: HDAC11
3 Cross references
202 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSPNAG00000019553
Gene Symbol: LOC108416127
2 Cross references
209 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSPNAG00000022978
Gene Symbol: HDAC3
4 Cross references
155 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSPNAG00000013918
Gene Symbol: HDAC4
3 Cross references
202 Possible Orthologues:

Histone Deacetylase 4-Like

Ensembl ID : ENSPNAG00000010355
Gene Symbol: LOC108436449
2 Cross references
196 Possible Orthologues:

Histone Deacetylase 4-Like

Ensembl ID : ENSPNAG00000002603
Gene Symbol: LOC108441074
2 Cross references
195 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSPNAG00000018413
Gene Symbol: HDAC5
3 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).